Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
出版年份 2022 全文链接
标题
Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages -
出版商
American Chemical Society (ACS)
发表日期
2022-02-18
DOI
10.1021/acs.jmedchem.1c01758
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification of novel potent HIV-1 inhibitors by exploiting the tolerant regions of the NNRTIs binding pocket
- (2021) Yanying Sun et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Covalent Inhibition of Wild-Type HIV-1 Reverse Transcriptase Using a Fluorosulfate Warhead
- (2021) Joseph A. Ippolito et al. ACS Medicinal Chemistry Letters
- Avoiding Drug Resistance in HIV Reverse Transcriptase
- (2021) Maria E. Cilento et al. CHEMICAL REVIEWS
- 2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies
- (2021) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hydrophobic Pocket Occupation Design of Difluoro-Biphenyl-Diarylpyrimidines as Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors: from N-Alkylation to Methyl Hopping on the Pyrimidine Ring
- (2021) Li Ding et al. JOURNAL OF MEDICINAL CHEMISTRY
- ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties
- (2021) Guoli Xiong et al. NUCLEIC ACIDS RESEARCH
- Improving Druggability of Novel Diarylpyrimidine NNRTIs by a Fragment-Based Replacement Strategy: From Biphenyl-DAPYs to Heteroaromatic-Biphenyl-DAPYs
- (2021) Li Ding et al. JOURNAL OF MEDICINAL CHEMISTRY
- HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites
- (2021) Natalie Losada et al. JOURNAL OF MEDICINAL CHEMISTRY
- Doravirine: its role in HIV treatment
- (2021) Alexander J. Stockdale et al. Current Opinion in HIV and AIDS
- Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?
- (2021) Neeraja Bhavaraju et al. Current HIV/AIDS Reports
- Application of Negative Design To Design a More Desirable Virtual Screening Library
- (2020) Zi-Yi Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology
- (2020) Chiara Borsari et al. JOURNAL OF MEDICINAL CHEMISTRY
- Medicinal chemistry strategies toward host targeting antiviral agents
- (2020) Xingyue Ji et al. MEDICINAL RESEARCH REVIEWS
- Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
- (2020) Susan Swindells et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
- (2020) Sangeun Jeon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Curing HIV: Seeking to Target and Clear Persistent Infection
- (2020) David M. Margolis et al. CELL
- Multiple approaches for achieving drug solubility: an in silico perspective
- (2020) Torsa Das et al. DRUG DISCOVERY TODAY
- In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBP
- (2020) Dongwei Kang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties
- (2020) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein
- (2020) Mingliang Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review
- (2020) William Gustavo Lima et al. ARCHIVES OF VIROLOGY
- Fsp3: A new parameter for drug-likeness
- (2020) Wenxiu Wei et al. DRUG DISCOVERY TODAY
- Cabotegravir Plus Rilpivirine: First Approval
- (2020) A. Markham DRUGS
- From combinations to multitarget‐directed ligands: A continuum in Alzheimer's disease polypharmacology
- (2020) Claudia Albertini et al. MEDICINAL RESEARCH REVIEWS
- Four Decades of HIV/AIDS — Much Accomplished, Much to Do
- (2020) Anthony S. Fauci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development
- (2020) Elizabeth Anne Martin et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Reconstitution and visualization of HIV-1 capsid-dependent replication and integration in vitro
- (2020) Devin E. Christensen et al. SCIENCE
- Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
- (2020) Edgar T Overton et al. LANCET
- Exploiting the tolerant region I of the non-nucleoside reverse transcriptase inhibitor (NNRTI) binding pocket. Part 2: Discovery of diarylpyrimidine derivatives as potent HIV-1 NNRTIs with high Fsp3 values and favorable drug-like properties
- (2020) Xiangyi Jiang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, and evaluation of “dual-site”-binding diarylpyrimidines targeting both NNIBP and the NNRTI adjacent site of the HIV-1 reverse transcriptase
- (2020) Da Feng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties
- (2019) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Aqueous Drug Solubility: What Do We Measure, Calculate and QSPR Predict?
- (2019) Oleg A. Raevsky et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles
- (2019) Boshi Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Accelerated drug discovery by rapid candidate drug identification
- (2019) Fredrik Bergström et al. DRUG DISCOVERY TODAY
- Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapy
- (2019) Ioannis D. Kyrochristos et al. DRUG DISCOVERY TODAY
- Fifty Years in Search of Selective Antiviral Drugs
- (2019) Erik De Clercq JOURNAL OF MEDICINAL CHEMISTRY
- Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
- (2019) Junting Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Overview of Recent Strategic Advances in Medicinal Chemistry
- (2019) Gaochan Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular design opportunities presented by solvent‐exposed regions of target proteins
- (2019) Xiangyi Jiang et al. MEDICINAL RESEARCH REVIEWS
- Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases
- (2019) Viktoriya Ivasiv et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Virion-associated, host-derived DHX9/RNA helicase A enhances the processivity of HIV-1 reverse transcriptase on genomic RNA
- (2019) Samantha Brady et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations
- (2019) Mélissanne de Wispelaere et al. Nature Communications
- Dolutegravir–rilpivirine for virological suppression
- (2019) Anton L Pozniak et al. Lancet HIV
- Doravirine: A Return of the NNRTI Class?
- (2019) Sarah R. Blevins et al. ANNALS OF PHARMACOTHERAPY
- Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains
- (2019) KaiJun Jin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment
- (2019) Yali Wang et al. Expert Opinion on Drug Metabolism & Toxicology
- A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
- (2019) Longchuan Bai et al. CANCER CELL
- Evolution of HIV-1 reverse transcriptase and integrase dual inhibitors: Recent advances and developments
- (2019) Muhammad Shoaib Ali Gill et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles
- (2019) Sheng Han et al. ACS Infectious Diseases
- Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial
- (2019) Jean-Michel Molina et al. Lancet HIV
- Current scenario of ferrocene-containing hybrids for antimalarial activity
- (2019) Jiaqi Xiao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Kinetic Target-Guided Synthesis: Reaching the Age of Maturity
- (2019) Damien Bosc et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles
- (2019) Yali Sang et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Structural View on Medicinal Chemistry Strategies against Drug Resistance
- (2018) Stefano Agnello et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Structure-based design of targeted covalent inhibitors
- (2018) Richard Lonsdale et al. CHEMICAL SOCIETY REVIEWS
- Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?
- (2018) Serge Mignani et al. DRUG DISCOVERY TODAY
- Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1
- (2018) KaiJun Jin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Emerging reverse transcriptase inhibitors for HIV-1 infection
- (2018) Mohammad A. Rai et al. EXPERT OPINION ON EMERGING DRUGS
- Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies
- (2018) Josep M Llibre et al. LANCET
- Computational chemical biology and drug design: Facilitating protein structure, function, and modulation studies
- (2018) Mingyue Zheng et al. MEDICINAL RESEARCH REVIEWS
- Architecture of an HIV-1 reverse transcriptase initiation complex
- (2018) Kevin P. Larsen et al. NATURE
- The expanding role of prodrugs in contemporary drug design and development
- (2018) Jarkko Rautio et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of Novel Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the “NNRTI Adjacent” Binding Site
- (2018) Zhipeng Huo et al. ACS Medicinal Chemistry Letters
- Doravirine
- (2018) Marie-Alice Colombier et al. Current Opinion in HIV and AIDS
- Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial
- (2018) Jean-Michel Molina et al. Lancet HIV
- Tolerability of Current Antiretroviral Single-Tablet Regimens
- (2018) Pere Domingo et al. AIDS REVIEWS
- admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties
- (2018) Hongbin Yang et al. BIOINFORMATICS
- Lead-like Drugs: A Perspective
- (2018) Brian Raymer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficient drug discovery by rational lead hybridization based on crystallographic overlay
- (2018) Shuo Zhang et al. DRUG DISCOVERY TODAY
- Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inhibitors
- (2018) Lanlan Jing et al. DRUG DISCOVERY TODAY
- Doravirine: First Global Approval
- (2018) Emma D. Deeks DRUGS
- Dolutegravir/Rilpivirine: A Review in HIV-1 Infection
- (2018) Hannah A. Blair DRUGS
- Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
- (2018) Matthias Gehringer et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic
- (2018) Vigneshwaran Namasivayam et al. JOURNAL OF MEDICINAL CHEMISTRY
- Challenges and approaches in the discovery of human immunodeficiency virus type-1 non-nucleoside reverse transcriptase inhibitors
- (2018) Leandro Battini et al. MEDICINAL RESEARCH REVIEWS
- Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs
- (2018) Zhao Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants
- (2017) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Host-directed therapies for bacterial and viral infections
- (2017) Stefan H. E. Kaufmann et al. NATURE REVIEWS DRUG DISCOVERY
- Dapivirine Vaginal Ring for HIV-1 Prevention
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- HIV Drug Resistance — An Emerging Threat to Epidemic Control
- (2017) Chris Beyrer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography
- (2017) Albert H. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection
- (2017) Shalley N. Kudalkar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase
- (2016) Shuang-Xi Gu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries
- (2016) Xueshun Wang et al. DRUG DISCOVERY TODAY
- Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles
- (2016) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the Aryl-phospho-indole IDX899, a Highly Potent Anti-HIV Non-nucleoside Reverse Transcriptase Inhibitor
- (2016) Cyril Dousson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus
- (2016) Na Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent Advances in Scaffold Hopping
- (2016) Ye Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women
- (2016) Annalene Nel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants
- (2016) Steven J. Smith et al. Retrovirology
- Design, Conformation, and Crystallography of 2-Naphthyl Phenyl Ethers as Potent Anti-HIV Agents
- (2016) Won-Gil Lee et al. ACS Medicinal Chemistry Letters
- Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants
- (2015) Kathleen M. Frey et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends
- (2015) Peng Zhan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates
- (2015) Zhiyan Xiao et al. MEDICINAL RESEARCH REVIEWS
- HIV-1 capsid: the multifaceted key player in HIV-1 infection
- (2015) Edward M. Campbell et al. NATURE REVIEWS MICROBIOLOGY
- Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance
- (2015) William T. Gray et al. ACS Medicinal Chemistry Letters
- The HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (Part V ☆ ): Capravirine and Its Analogues
- (2015) X. Li et al. CURRENT MEDICINAL CHEMISTRY
- In VitroResistance Selection with Doravirine (MK-1439), a Novel Nonnucleoside Reverse Transcriptase Inhibitor with Distinct Mutation Development Pathways
- (2014) Meizhen Feng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Conformational restriction: an effective tactic in 'follow-on'-based drug discovery
- (2014) Zengjun Fang et al. Future Medicinal Chemistry
- Picomolar Inhibitors of HIV-1 Reverse Transcriptase: Design and Crystallography of Naphthyl Phenyl Ethers
- (2014) Won-Gil Lee et al. ACS Medicinal Chemistry Letters
- Unexpected finding of delayed-onset seizures in HIV-positive, treatment-experienced subjects in the phase IIb evaluation of fosdevirine (GSK2248761)
- (2013) David A Margolis et al. ANTIVIRAL THERAPY
- Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses
- (2013) Bernard Côté et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Multivalent Agents: A Novel Concept and Preliminary Practice in Anti-HIV Drug Discovery
- (2013) Yu'ning Song et al. CURRENT MEDICINAL CHEMISTRY
- Rationally Designed Multitarget Anti-HIV Agents
- (2013) P. Zhan et al. CURRENT MEDICINAL CHEMISTRY
- The holistic integration of virtual screening in drug discovery
- (2013) Yusuf Tanrikulu et al. DRUG DISCOVERY TODAY
- Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening
- (2013) Joseph D. Bauman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Pyridinone Derivatives As Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) with High Potency against NNRTI-Resistant HIV-1 Strains
- (2013) Amin Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cell-Based Medicinal Chemistry Optimization of High-Throughput Screening (HTS) Hits for Orally Active Antimalarials. Part 1: Challenges in Potency and Absorption, Distribution, Metabolism, Excretion/Pharmacokinetics (ADME/PK)
- (2013) Arnab K. Chatterjee JOURNAL OF MEDICINAL CHEMISTRY
- Bifunctional Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Mechanism and Proof-of-Concept as a Novel Therapeutic Design Strategy
- (2013) Christopher M. Bailey et al. JOURNAL OF MEDICINAL CHEMISTRY
- Thermodynamics of HIV-1 Reverse Transcriptase in Action Elucidates the Mechanism of Action of Non-Nucleoside Inhibitors
- (2013) Guillaume Bec et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Picomolar Inhibitors of HIV Reverse Transcriptase Featuring Bicyclic Replacement of a Cyanovinylphenyl Group
- (2013) Won-Gil Lee et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations
- (2013) Michael Roche et al. Retrovirology
- Design, Synthesis, and Antiviral Evaluation of Chimeric Inhibitors of HIV Reverse Transcriptase
- (2013) Pinar Iyidogan et al. ACS Medicinal Chemistry Letters
- HIV-1 reverse transcriptase and antiviral drug resistance. Part 1
- (2013) Kalyan Das et al. Current Opinion in Virology
- HIV-1 reverse transcriptase and antiviral drug resistance. Part 2
- (2013) Kalyan Das et al. Current Opinion in Virology
- Exploiting the Reversible Covalent Bonding of Boronic Acids: Recognition, Sensing, and Assembly
- (2012) Steven D Bull et al. ACCOUNTS OF CHEMICAL RESEARCH
- Central Nervous System Disposition and Metabolism of Fosdevirine (GSK2248761), a Non-Nucleoside Reverse Transcriptase Inhibitor: An LC-MS and Matrix-Assisted Laser Desorption/Ionization Imaging MS Investigation into Central Nervous System Toxicity
- (2012) Stephen Castellino et al. CHEMICAL RESEARCH IN TOXICOLOGY
- In search of a treatment for HIV – current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs)
- (2012) Chevonne Reynolds et al. CHEMICAL SOCIETY REVIEWS
- Structure-based methods for predicting target mutation-induced drug resistance and rational drug design to overcome the problem
- (2012) Ge-Fei Hao et al. DRUG DISCOVERY TODAY
- Strategies for the Design of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Lessons from the Development of Seven Representative Paradigms
- (2012) Dongyue Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Preclinical Evaluations of Novel 4-Substituted 1,5-Diarylanilines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Drug Candidates
- (2012) Lian-Qi Sun et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of 1-[(2-Benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance Profile
- (2012) Xiaowei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design
- (2012) Kathleen M. Frey et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants
- (2012) Barry C Johnson et al. Retrovirology
- Design and synthesis of pyridone inhibitors of non-nucleoside reverse transcriptase
- (2011) Robert Gomez et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Classification of scaffold-hopping approaches
- (2011) Hongmao Sun et al. DRUG DISCOVERY TODAY
- Computationally-Guided Optimization of a Docking Hit to Yield Catechol Diethers as Potent Anti-HIV Agents
- (2011) Mariela Bollini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Conformationally Constrained Inhibitors of Non-Nucleoside Reverse Transcriptase
- (2011) Robert Gomez et al. JOURNAL OF MEDICINAL CHEMISTRY
- 3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase
- (2011) Jing Tang et al. JOURNAL OF MEDICINAL CHEMISTRY
- HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design
- (2011) Peng Zhan et al. MEDICINAL RESEARCH REVIEWS
- Turning the Tide Against HIV
- (2011) R. J. Shattock et al. SCIENCE
- Pharmacophore and structure–activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase
- (2010) Zhengqiang Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Accounting for Ligand Conformational Restriction in Calculations of Protein-Ligand Binding Affinities
- (2010) Cen Gao et al. BIOPHYSICAL JOURNAL
- Kinetic target-guided synthesis
- (2010) Xiangdong Hu et al. CHEMICAL SOCIETY REVIEWS
- In situ click chemistry: probing the binding landscapes of biological molecules
- (2010) Sreeman K. Mamidyala et al. CHEMICAL SOCIETY REVIEWS
- Targeting the protein–protein interactions of the HIV lifecycle
- (2010) Ali Tavassoli CHEMICAL SOCIETY REVIEWS
- Diarylaniline Derivatives as a Distinct Class of HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
- (2010) Bingjie Qin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Evaluation of Diarylpyridines and Diarylanilines as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors
- (2010) Xingtao Tian et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design
- (2010) Eric B. Lansdon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization
- (2010) Sarah R. Langdon et al. Molecular Informatics
- The disposition and metabolism of GW695634: A non-nucleoside reverse transcriptase inhibitor (NNRTi) for treatment of HIV/AIDS
- (2010) Mark de Serres et al. XENOBIOTICA
- N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and Integrase
- (2010) Jing Tang et al. ACS Medicinal Chemistry Letters
- Antiviral Activity of MK-4965, a Novel Nonnucleoside Reverse Transcriptase Inhibitor
- (2009) M.-T. Lai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design Strategies of Novel NNRTIs to Overcome Drug Resistance
- (2009) Peng Zhan et al. CURRENT MEDICINAL CHEMISTRY
- Designed Multiple Ligands: An Emerging Anti-HIV Drug Discovery Paradigm
- (2009) Peng Zhan et al. CURRENT PHARMACEUTICAL DESIGN
- Discovery of Wild-Type and Y181C Mutant Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors Using Virtual Screening with Multiple Protein Structures
- (2009) Sara E. Nichols et al. Journal of Chemical Information and Modeling
- Molecular Dynamics Study of Non-nucleoside Reverse Transcriptase Inhibitor 4-[[4-[[4-[(E)-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (TMC278/Rilpivirine) Aggregates: Correlation between Amphiphilic Properties of the Drug and Oral Bioavailability
- (2009) Yulia Volovik Frenkel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
- (2009) Frank Lovering et al. JOURNAL OF MEDICINAL CHEMISTRY
- Conformational Landscape of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Non-Nucleoside Inhibitor Binding Pocket: Lessons for Inhibitor Design from a Cluster Analysis of Many Crystal Structures
- (2009) Kristina A. Paris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
- (2009) Youcef Mehellou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: Introducing a diketoacid functionality into delavirdine
- (2008) Zhengqiang Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase
- (2008) Zachary K. Sweeney et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase
- (2008) Zachary K. Sweeney et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The design and synthesis of diaryl ether second generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) with enhanced potency versus key clinical mutations
- (2008) Thomas J. Tucker et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of 3-{5-[(6-Amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): A Potent, Orally Bioavailable HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor with Improved Potency against Key Mutant Viruses
- (2008) Thomas J. Tucker et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design of Annulated Pyrazoles as Inhibitors of HIV-1 Reverse Transcriptase∥
- (2008) Zachary K. Sweeney et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design
- (2008) Joseph D. Bauman et al. NUCLEIC ACIDS RESEARCH
- High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations
- (2008) K. Das et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fluorine in medicinal chemistry
- (2007) Sophie Purser et al. CHEMICAL SOCIETY REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now